IP Library Granted Patent US 11,730,168
Granted Patent B2
US 11,730,168 · App. 16/753,570 · Granted Aug 22, 2023

Antimicrobial superabsorbent compositions

Inventors: Thomas Hall (Birmingham, GB); Sophie Constance Cox (Birmingham, GB); Liam Michael Grover (Birmingham, GB); David Kershaw (Abingdon, GB)
Assignee: Matoke Holdings Limited
A01N59/00A01N63/50A61K9/06A61K38/363A61K38/443A61K38/4833A61K47/26A61K47/32A61K47/40A61L26/008A61L26/0014A61L26/0042A61L26/0047A61L26/0066A61L26/0095C12Y101/03004
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,730,168
App. No.
16/753,570
Granted
Aug 22, 2023
Kind
B2
Abstract

A composition has an enzyme that is able to convert a substrate to release hydrogen peroxide; a substrate for the enzyme; and a superabsorbent component, such as a superabsorbent polymer. The composition is in the form of a powder and may form a gel on contact with water.

Claims (28)

1. A sterile composition comprising:

an enzyme that is able to convert a substrate to release hydrogen peroxide;

a substrate for the enzyme; and

a superabsorbent component,

wherein the composition is in the form of a powder, wherein the powder has a mean and/or modal particle diameter of 3000 μm or less, and wherein the composition does not contain any peroxidase.

2. A composition according to claim 1 , wherein the superabsorbent component has an absorption capacity of at least 10 g/g.

3. A composition according to claim 1 , wherein the absorption capacity is in respect of deionized water, distilled water, or a 0.9% (by weight) saline solution.

4. A composition according to claim 1 , wherein the superabsorbent component is a superabsorbent polymer.

5. A composition according to claim 4 , wherein:

a) the superabsorbent polymer is anionic; and/or

b) the superabsorbent polymer is cross-linked; and/or

c) the superabsorbent polymer is polyacrylate or polyacrylamide.

6. A composition according to claim 4 , wherein the superabsorbent polymer is selected from the group consisting of: a hydrolysed cellulose-polyacrylonitrile; a starch-polyacrylonitrile co-polymer; a cross-linked co-polymer of maleic anhydride; polyvinyl alcohol co-polymer; and cross-linked polyethylene oxide.

7. A composition according to claim 1 , wherein the powder has a mean and/or modal particle diameter of 100 μm to 2000 μm.

8. A composition according to claim 1 , wherein the enzyme is an oxidoreductase enzyme.

9. A composition according to claim 1 , wherein the substrate is a sugar.

10. A composition according to claim 1 , comprising a solute in the form of a sugar or sugar derivative having a solubility of at least 100 g/100 g water at 20° C. and 1 atm.

11. A composition according to claim 1 , wherein the composition:

a) Lacks catalase activity; and/or

b) Comprises a blood clotting agent; and/or

c) Does not contain zinc oxide; and/or

d) Comprises a coagulation factor.

12. A composition according to claim 1 , comprising a freeze-drying protective agent.

13. A wound dressing which comprises a dressing material and a composition according to claim 1 .

14. An airtight container comprising a composition according to claim 1 , the container comprising a one or a plurality of apertures for permitting dispensing of the composition, the one or plurality of apertures being sealed or covered prior to use.

15. A method for making a composition according to claim 1 , comprising contacting a superabsorbent component with an enzyme that is able to convert a substrate to release hydrogen peroxide and a substrate for the enzyme.

16. A method of preventing, treating, or ameliorating a microbial infection, which comprises administering a composition according to claim 1 , to a subject in need of such prevention, treatment or amelioration.

17. A method of treating a wound, which comprises administering a composition according to claim 1 to a wound site.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2022
From: HALL, THOMAS JON; COX, SOPHIE CONSTANCE; GROVER, LIAM MICHAEL
To: THE UNIVERSITY OF BIRMINGHAM
Reel/Frame 061773/0366 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2022
From: KERSHAW, DAVID
To: MATOKE HOLDINGS LIMITED
Reel/Frame 061773/0842 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2022
From: THE UNIVERSITY OF BIRMINGHAM
To: MATOKE HOLDINGS LIMITED
Reel/Frame 061774/0298 →
Priority Claims (1)
GB 1716986 · Oct 16, 2017 · national
Continuity (1)
Related Publication 20200289701A1 · Sep 17, 2020